Global Contrast Media Injectors Market is anticipated to grow on the backbone of technological advancements in the medical devices.
According to TechSci Research report, “Global Contrast Media Injectors Market By Product (Injector Systems v/s Consumables) By Injector Type (Single-head, Dual-head, Syringeless) By Application (Radiology, Interventional Cardiology, Others) By End User (Hospitals & Clinics, Ambulatory Care Centers, Diagnostic Centers) By Region, Competition Forecast & Opportunities, 2026”, the global contrast media injectors market is anticipated to grow in the forecast period from 2022 to 2026. Facts like IT enabled solutions for syringeless, dual-head, and automated injectors are expected to drive the market growth with an impressive CAGR in upcoming five years. Syringeless injectors are easier to use, and quite efficient. It allows to avoid the contrast agent wastage that may arise otherwise, also it provides contrast enhancement during imaging. Diagnostics require contrast media injectors to enhance blood and perfusion in tissues, and other processes to identify the issues. These processes were earlier carried out through invasive surgeries. Increased preference by patients for non-invasive, or minimally invasive procedures is driving the growth of global contrast media injectors market in next five years.
Moreover, surge in demand for non-invasive and minimally invasive surgery procedures is driving the growth of global contrast media injectors market in the forecast period. The process provides various perks over the main-line surgery procedures like, smaller incisions, rapid wound healing, shorter hospital stays, less pain, and minor surgical wounds. Procedures conducted with the contrast media injectors provide high quality, and real time imaging for the diagnostic or surgical procedures that creates a convenient opportunity for the surgeons allowing them to perform the surgery at the appropriate area. This factor is one of the major factors that is actively driving the global contrast media injector market growth in next five years.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on “Global Contrast media injectors Market”
The global contrast media injectors market is segmented on the basis of product, injector type, application, end user, regional distribution, and competitional landscape. Based on the injector type, the market is further categorized into single-head, dual-head, and syringeless. Single-head injector segment is anticipated to assert its dominance over the market in the forecast years. The wide range of usage of single-head injector as in angiography, CT, and MRI, drives the growth of the market segment. Moreover, single-head injectors are more cost effective than its competitor injector systems.
Thus, these products are more preferred in the developing nations like India, China, and Brazil.
Based on end user, the market is bifurcated into hospitals & clinics, ambulatory care centers, and diagnostic centers. Hospitals and clinics hold the largest market share and is expected to dominate the market segment owing to the increasing number of patients being admitted for the target diseases like cancer, cardiovascular disorders, and neurological disorders. Radiology department in the hospitals have the wide range of applications of contrast media injectors thereby driving the growth of the market segment. With the number of patients turnaround and readmissions in the hospitals the segment can well versed be said that it is anticipated to dominate the market in upcoming five years.
Some of the major competitors in the market are Bracco Imaging S.P.A, Bayer A.G., Guerbet Group, Ulrich GmbH & Co. KG, Nemoto Kyorindo Co., Ltd, Sino Medical-Device Technology Co., Ltd. (Sinomdt), APOLLO RT Co. Ltd., Shenzhen Anke High-tech Co. Ltd, Shenzen Seacrown Electromechanical Co Ltd., Medtron AG, among others. With technical advancements in the contrast media injectors, the market is anticipated to grow. Top players with their elaborative research and development of more efficient devices would drive the growth of the market. These activities along with partnerships and alliances would benefit the competitors to stabilize their market share.
Download Sample Report @https://www.techsciresearch.com/sample-report.aspx?cid=7366
Customers can also request for 10% free customization on this report.
“Radiology involves the maximum application of the contrast media injectors for the early and feasible detection of carcinogenic cells, cardiovascular diseases, heart conditions, breast cancer, broken bones, gastrointestinal conditions, and blood clots in the veins. The life threatening diseases often involves elaborative and prolonged surgeries, if diagnostics and other surgical procedures can be conducted in a non-invasive or minimally invasive process, it is a beneficial factor for the patient and eradicates the chances of post-surgery complications. North American region may dominate the market owing to its excellent healthcare facility although European region with several major players of the market would have significant revenue share too,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.
“Global Contrast Media Injectors Market By Product (Injector Systems v/s Consumables) By Injector Type (Single-head, Dual-head, Syringeless) By Application (Radiology, Interventional Cardiology, Others) By End User (Hospitals & Clinics, Ambulatory Care Centers, Diagnostic Centers) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of Global Contrast media injectors and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Contrast media injectors.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017